Pisgah Laboratories

Pisgah Laboratories is a contract development and manufacturing organization (CDMO) based in Old Fort, North Carolina, specializing in the synthesis and production of active pharmaceutical ingredients (APIs). Established in 1981, the company offers a comprehensive suite of services including process chemistry, analytical development, and cGMP manufacturing for clinical and commercial supply. Pisgah is particularly recognized for its expertise in handling controlled substances and its portfolio of proprietary salt forms and polymorphs of existing drugs. In 2018, the company was acquired by the Indian pharmaceutical giant Ipca Laboratories to serve as a strategic hub for its U.S. manufacturing and R&D operations. The facility is DEA-registered and FDA-inspected, supporting the development of complex small molecule therapeutics across various indications.